Square Pharma

Foreigners offload Tk161cr in May as sell-off in Square Pharma, BRAC Bank intensifies

This staggering imbalance highlights a deepening risk aversion among global fund managers, who appear to be prioritising liquidity and safe-haven assets over frontier-market exposure.

Sharp Industries shares have surged despite continued losses and no undisclosed price-sensitive information, according to the company, today (3 August). Photo: Collected.

Foreigners prefer Square Pharma, BRAC Bank in February, but pull back from Olympic, GP

Square Pharma revenue jumps 15% to Tk4,338cr in H1

Square Pharma

Square Pharma

Foreigners offload Tk161cr in May as sell-off in Square Pharma, BRAC Bank intensifies

Foreigners prefer Square Pharma, BRAC Bank in February, but pull back from Olympic, GP

Square Pharma revenue jumps 15% to Tk4,338cr in H1

Square Pharma director Ratna Patra to buy 10 lakh shares

Tapan Chowdhury plans Tk40cr share purchase in Square Pharma

Square Pharma unveils Tk650cr expansion plan, declares record 120% dividend

Square Pharma posts double-digit growth, earns Tk5,785cr in 9 months

Square Pharma declares record dividend, Tk500cr expansion plan

Square Pharma earns Tk6,286cr revenue in nine months

Square Pharma chairman announces to buy 20 lakh shares

Another Square Pharma director to buy 10 lakh shares worth Tk21cr

Square Pharma's two directors to buy 20 lakh shares worth Tk42 crore

Dengue outbreak boon for Square Pharma